POTENT ANTITUMOR EFFICACY OF EX VIVO EXPANDED AND CRYOPRESERVED HUMAN NATURAL KILLER CELLS AGAINST ORTHOTOPIC PANCREATIC CANCER

被引：0
|
作者：
Park, G. [1 ]
Yang, B. [1 ]
Kim, E. [1 ]
Kim, H. [1 ]
Kim, Y. [1 ]
Cho, S. [1 ]
Hwang, Y. [1 ]
Min, B. [1 ]
机构：
[1] GCLabcell, Yongin, Gyeonggi Do, South Korea
来源：
CYTOTHERAPY | 2019年 / 21卷 / 05期
关键词：
D O I：
10.1016/j.jcyt.2019.03.361
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
91
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [21] Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer
    Vo, Manh-Cuong
    Nguyen, Van-Tan
    Tran, Van-Dinh-Huan
    Oh, Hyung-Joo
    Jung, Sung-Hoon
    Bae, Woo Kyun
    Lee, Je-Jung
    Oh, In-Jae
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [22] INCREASED REACTIVITY OF CIRCULATING NATURAL KILLER CELLS FOLLOWING ADOPTIVE TRANSFER OF EX VIVO EXPANDED NATURE KILLER CELLS
    Deng, X.
    Terunuma, H.
    Terunuma, A.
    Takane, T.
    Nieda, M.
    CYTOTHERAPY, 2014, 16 (04) : S19 - S19
  • [23] In Vitro and In Vivo Antitumor Efficacy of Docetaxel and Sorafenib Combination in Human Pancreatic Cancer Cells
    Ulivi, P.
    Arienti, C.
    Zoli, W.
    Scarsella, M.
    Carloni, S.
    Fabbri, F.
    Tesei, A.
    Chiadini, E.
    Orlandi, A.
    Passeri, D.
    Zupi, G.
    Milandri, C.
    Silvestrini, R.
    Amadori, D.
    Leonetti, C.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (06) : 600 - 610
  • [24] GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
    Lim, Okjae
    Lee, Yuna
    Chung, Hyejin
    Her, Jung Hyun
    Kang, Sang Mi
    Jung, Mi-Young
    Min, Bokyung
    Shin, Hyejin
    Kim, Tae Min
    Heo, Dae Seog
    Hwang, Yu Kyeong
    Shin, Eui-Cheol
    PLOS ONE, 2013, 8 (01):
  • [25] HIGH AND SELECTIVE CYTOTOXICITY OF EX VIVO EXPANDED ALLOGENEIC HUMAN NATURAL KILLER CELLS FROM PERIPHERAL BLOOD AGAINST BLADDER CANCER: IMPLICATIONS FOR NATURAL KILLER CELL INSTILLATION AFTER TRANSURETHRAL RESECTION OF BLADDER TUMOR
    Wang, Fangming
    JOURNAL OF UROLOGY, 2024, 211 (05): : E357 - E357
  • [26] High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
    Wang, Fangming
    Zhang, Gang
    Xu, Tianli
    Ma, Jianlin
    Wang, Jing
    Liu, Shuai
    Tang, Yuzhe
    Jin, Song
    Li, Jianxing
    Xing, Nianzeng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [27] High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
    Fangming Wang
    Gang Zhang
    Tianli Xu
    Jianlin Ma
    Jing Wang
    Shuai Liu
    Yuzhe Tang
    Song Jin
    Jianxing Li
    Nianzeng Xing
    Journal of Experimental & Clinical Cancer Research, 43
  • [28] Ex vivo expanded autologous natural killer cells as a novel therapeutic approach in multiple myeloma
    Alici, Evren
    Sutlu, Tolga
    Bjokstrand, Bo
    Gilljam, Mari
    Stellan, Birgitta
    Nahi, Hareth
    Quezada, Hernan Concha
    Gahrton, Gosta
    Ljunggren, Hans-Gustaf
    Dilber, M. Sirac
    HUMAN GENE THERAPY, 2008, 19 (10) : 1183 - 1183
  • [29] Non-clonal chromosome aberrations in ex vivo expanded natural killer cells for immunotherapy
    Yulong, L.
    Zhoufeng, H.
    Lei, L. Z.
    Chengye, W.
    Kai, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 453 - 453
  • [30] Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer
    Chen, Xiaoming
    Ding, Xia
    Fang, Jiebin
    Mao, Churu
    Gong, Xingzhi
    Zhang, Yuxiao
    Zhang, Ningjing
    Yan, Feihang
    Lou, Yijie
    Chen, Zhe
    Ding, Wanjing
    Ma, Zhongjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (16) : 14609 - 14632
12345